• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 11793

10-year publication summary

378
567
989
1225
1204
1426
1485
1566
1553
781
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
SeaGen Inc
580
250
Regeneron Pharmaceuticals, Inc.
4223
200
Daiichi Sankyo Company, Limited
1852
198
Genentech, Inc.
3961
194
MedImmune Limited
611
149
Hanmi Pharm. Co., Ltd.
569
148
ImmunoGen, Inc.
399
130
Dyne Therapeutics, Inc.
238
127
The Regents of the University of California
19812
115
Novartis AG
10904
91
Bristol-myers Squibb Company
4892
90
Bolt Biotherapeutics, Inc.
119
90
Pfizer Inc.
3367
76
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
279
66
ADC Therapeutics SA
126
65
Hoffmann-La Roche Inc.
3379
60
Memorial Sloan-Kettering Cancer Center
1910
59
Abbvie Inc.
1802
58
CytomX Therapeutics, Inc.
216
58
Hangzhou DAC Biotech Co., Ltd
102
58
Other owners 9511